The Invesco MSCI EAFE Income Advantage ETF (EFAA) delivers an 8% yield by combining international equities with equity-linked notes, maintaining a lower expense ratio than its peers. It outperforms its benchmark MSCI EAFE ETF (EFA) on risk-adjusted returns but lags behind competitor IDVO in both total and risk-adjusted returns since inception. The current market environment favors ETFs like EFAA that generate income while managing risk, making it suitable for investors prioritizing yield and lower fees. However, its relatively short track record means investors should consider their risk tolerance and investment goals when choosing between EFAA and alternatives like IDVO.
Wolters Kluwer repurchased 499 of its ordinary shares between October 29 and November 4, 2026, spending €0.04 million at an average price of €85.06 per share. This is part of a larger 2026 share buyback program aiming to repurchase shares worth up to...
Lorenz Snacks has introduced a fleet of four autonomous, electric vehicles from Einride at its production site in Neunburg vorm Wald, Germany. These vehicles will handle in-plant transport of goods and materials, replacing diesel trucks and significa...
Futu Holdings Limited will announce its financial results for the third quarter ending September 30, 2026, on November 19 before U.S. market open. The company will host a live earnings conference call at 7:30 AM ET (8:30 PM Beijing/Hong Kong time) th...
UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This chan...
T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will ...
